Paramagnetic Rim Lesions Showing Promise as Diagnostic Marker of MS
Inflammatory lesions within the brain, called paramagnetic rim lesions, visible on imaging scans may improve the accuracy of a multiple…
Articles by Forest Ray PhD
Better Efforts Needed to Prevent Urinary Tract Infections in MS Patients
Urinary tract infections are a common cause of hospitalization among people with multiple sclerosis (MS), especially older patients with…
35% of Newly Diagnosed Patients Given DMT in Follow-up Years, US Study Finds
Almost two-thirds of people newly diagnosed with multiple sclerosis (MS) in the United States, identified through a national database,…
Aubagio Shows Long-term Safety, Efficacy in Relapsing MS Extension Study
Aubagio (teriflunomide), taken as a 14 mg tablet once a day, shows long-term safety and efficacy in patients with relapsing…
Donepezil Seen to Aid Cognition, Life Quality for MS Patients in Small Trial
Donepezil — an approved treatment for Alzheimer’s disease — eased cognitive impairment, depression, and improved other quality-of-life measures in multiple sclerosis (MS)…
Healthcare Access for Immigrants With MS in Ontario ‘Reassuring,’ Study Finds
Immigrants with multiple sclerosis (MS) in Ontario use public health services as much as long-term residents, but are more…
Lower Urinary Tract Symptoms Should Be Assessed in MS Cases
Clinical evaluation of multiple sclerosis (MS) patients should include the assessment of lower urinary tract symptoms (LUTS) alongside neurological…
Video Game Therapy Shows Potential for Cognitive Gains in Small Study
An interactive video game was more effective than a word game at improving processing speeds in multiple sclerosis (MS)…
Bafiertam, for Adults With Relapsing MS, Available in US in September
Banner Life Sciences announced that Bafiertam (monomethyl fumarate) will become available to adults with relapsing forms of multiple…
National MS Society Invests $16M in Disease Research, Physician Training
The National Multiple Sclerosis Society announced investments of more than $16 million to support 50 new multi-year research projects and…
Vital Neurological Care Missing During Pandemic, UK Survey Finds
The ongoing COVID-19 pandemic is disrupting vital care and support for those with neurological disorders like multiple sclerosis…
Progentec Signs Agreements to Develop, Commercialize MS Technologies
Progentec has established new licensing agreements with Stanford University and the Oklahoma Medical Research Foundation to commercialize and…
Study of Temelimab in MS Progression Without Relapse Enrolls 1st Patient
GeNeuro announced that a first multiple sclerosis (MS) patient has enrolled in its Phase 2 trial assessing the safety and effectiveness…
1st Progressive MS Patient Enrolls in Phase 1b Study of Cell Therapy ATA188
Atara Biotherapeutics has enrolled a first patient in a clinical trial testing ATA188, its off-the-shelf T-cell immunotherapy for people…
CMSC Meeting Focuses on Challenges, Solutions to Quality of Life Issues
Nearly 3,000 multiple sclerosis (MS) healthcare providers and researchers  convened recently to share their findings regarding the latest developments…
Immune B-cell Subsets Correlate with MS Progression, Study Finds
Australian scientists have discovered subsets of immune cells that differ between people who have multiple sclerosis (MS)…
Blood Levels of Nerve Cell Protein Likely Marker of Brain Injury to Come
A nerve cell protein found in the blood shows potential as a biomarker of neuroinflammation and future neurodegeneration in…
THC:CBD Oral Spray Sativex Provides Consistent Relief for Treatment-resistant MS Spasticity
Sativex (nabiximols), a THC:CBD oral spray, consistently relieves the pain and severity of treatment-resistant spasticity in…
Researchers Study Cognitive Decline in Older MS Patients for Alzheimer’s Link
As multiple sclerosis (MS) patients live longer, researchers have observed similarities between changes in their brains and in…
Cellular Metabolism Could Be New Therapeutic Target in MS, Study Suggests
Immune system cells can either trigger or suppress inflammation by controlling mitochondrial respiration — the process that…
University Spin-Off Pheno Therapeutics to Search for Compounds to Re-Grow Myelin Lost in MS
Pheno Therapeutics, a spin-off from the University of Edinburgh, in Scotland, will search for new molecules capable…
Multiple Factors Influence the Prevalence of Lower Urinary Tract Symptoms in MS Patients, Study Indicates
Age, gender, disease subtype, degree of disability, and more factors affect lower urinary tract symptoms (LUTS) among patients with…